Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, 221 85, Lund, Sweden.
Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
Breast Cancer Res Treat. 2022 Nov;196(1):185-196. doi: 10.1007/s10549-022-06664-7. Epub 2022 Aug 30.
To study the risk of incident breast cancer and subtype-specific breast cancer in relation to excess body weight in a contemporary Swedish prospective cohort study, The Karolinska Mammography Project for Risk Prediction of Breast Cancer, KARMA.
A total of 35,412 postmenopausal women attending mammography and included in the KARMA study provided baseline data on body mass index (BMI) and potential confounders. During eight years of follow-up, 822 incident invasive breast cancer cases were identified.
Women with overweight (BMI ≥ 25-< 30 kg/m) constituting 34% of the study cohort had an increased risk of incident breast cancer with an adjusted Hazard Ratio (HR) 1.19 (95% CI 1.01-1.4). A similar, however, non-significant, association was found for women with obesity (BMI ≥ 30 kg/m) conferring 13% of the cohort, with a HR of 1.19 (95% CI 0.94-1.5). Overweight was associated with risk of node-negative disease (HR 1.29, 95% CI 1.06-1.58), whereas obesity was associated with node-positive disease (HR 1.64, 95% CI 1.09-2.48). Both overweight and obesity were associated with risk of estrogen receptor positive (ER+) disease (HR 1.20, 95% CI 1.00-1.44 and HR 1.33, 95% CI 1.03-1.71, respectively), and low-grade tumors (HR 1.25, 95% CI 1.02-1.54, and HR 1.40, 95% CI 1.05-1.86, respectively). Finally, obesity was associated with ER+HER2 negative disease (HR 1.37, 95% CI 1.05-1.78) and similarly luminal A tumors (HR 1.43, 95% CI 1.02-2.01).
Overweight and obesity are associated with an increased risk of developing breast cancer, specifically ER+, low-grade, and for obesity, node-positive, high-risk breast cancer indicating a further need for risk communication and preventive programs.
在 Karolinska 乳腺癌风险预测的前瞻性队列研究 Karolinska 乳腺摄影项目(KARMA)中,研究超重和肥胖与乳腺癌风险及亚型的关系。
35412 名绝经后女性参加了乳房 X 光检查并参与了 KARMA 研究,提供了体重指数(BMI)和潜在混杂因素的基线数据。在 8 年的随访期间,共发现 822 例浸润性乳腺癌病例。
34%的研究队列中 BMI 在超重范围内(BMI≥25-<30 kg/m2)的女性患浸润性乳腺癌的风险增加,校正后的风险比(HR)为 1.19(95%CI 1.01-1.4)。BMI 处于肥胖范围内(BMI≥30 kg/m2)的女性(占队列的 13%)也有类似但无统计学意义的关联,HR 为 1.19(95%CI 0.94-1.5)。超重与淋巴结阴性疾病风险相关(HR 1.29,95%CI 1.06-1.58),而肥胖与淋巴结阳性疾病风险相关(HR 1.64,95%CI 1.09-2.48)。超重和肥胖均与雌激素受体阳性(ER+)疾病风险相关(HR 分别为 1.20,95%CI 1.00-1.44 和 HR 1.33,95%CI 1.03-1.71),以及低级别肿瘤(HR 分别为 1.25,95%CI 1.02-1.54 和 HR 1.40,95%CI 1.05-1.86)相关。最后,肥胖与 ER+HER2 阴性疾病(HR 1.37,95%CI 1.05-1.78)和类似的管腔 A 型肿瘤(HR 1.43,95%CI 1.02-2.01)相关。
超重和肥胖与乳腺癌风险增加相关,特别是 ER+、低级别和肥胖的淋巴结阳性、高危乳腺癌,这表明需要进一步进行风险沟通和预防计划。